U.S. District Judge Michael P. Shea, sitting in the District of Connecticut, has announced that despite previous ties, he will not recuse himself from a significant drug price-fixing lawsuit involving Sandoz Inc. and other pharmaceutical firms. Notably, the defending attorneys from Sandoz are from Day Pitney LLP, where Judge Shea formerly held a partnership position.
This case draws attention not only due to its subject matter – allegations of price-fixing within the drug industry – but also for the personal history shared between Judge Shea and the counsel for Sandoz. In such situations, it is incumbent upon judges to steer a clear path between potential conflicts of interest, their professional integrity and the fair administration of justice.
Given Judge Shea’s past association with Day Pitney LLP, questions about potential bias could have been raised. However, in an affirmation of judicial impartiality, Judge Shea has chosen not to step aside from this case. His role will continue and in it, he will oversee the state enforcers’ price-fixing arguments against Sandoz Inc. and other named pharmaceutical companies.
Sandoz, a notable player in the pharmaceutical industry, thus finds itself on the receiving end of price-fixing claims argued by its own former legal associate. For more detailed information on this unfolding case and the implications it holds for legal and corporate circles, you may read here.